Updated Jul 16, 2026 · Last SEC filing 2026-07-10
AGIOS PHARMACEUTICALS, INC. (AGIO) has filed 19 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-07-10. 2 Form 8-K material event filings were reported by AGIO in the last 90 days. 1 Form 144 notices of proposed sale were filed for AGIO stock. InsiderAlpha tracks every AGIO SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.
| SIC classification | Pharmaceutical Preparations (SIC 2834) |
|---|---|
| SEC CIK | 0001439222 |
| Form 4 filings (90d) | 19 |
|---|---|
| Form 8-K filings (90d) | 2 |
| Form 144 notices (90d) | 1 |
| Latest Form 4 filing | 2026-07-10 |
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Backstrom Jay T. | Director | A — Grant or award | 1.4K | $0.00 | — | SEC | |
| Gheuens Sarah | Chief Medical Officer | M — Option exercise | 8.4K | $0.00 | — | SEC | |
| Gheuens Sarah | Chief Medical Officer | S — Open-market sale | 4.0K | $37.56 | $151K | SEC | |
| Smith Cynthia | Director | M — Option exercise | 2.8K | $0.00 | — | SEC | |
| Owen Adams Catherine | Director | M — Option exercise | 2.8K | $0.00 | — | SEC | |
| FOUSE JACQUALYN A | Director | M — Option exercise | 2.8K | $0.00 | — | SEC | |
| Ho Maykin | Director | M — Option exercise | 2.8K | $0.00 | — | SEC | |
| Ballal Rahul D. | Director | M — Option exercise | 2.8K | $0.00 | — | SEC | |
| CAPELLO JEFFREY D | Director | M — Option exercise | 2.8K | $0.00 | — | SEC | |
| Foster-Cheek Kaye I | Director | M — Option exercise | 2.8K | $0.00 | — | SEC | |
| Scadden David | Director | M — Option exercise | 2.8K | $0.00 | — | SEC | |
| CAPELLO JEFFREY D | Director | M — Option exercise | 2.0K | $0.00 | — | SEC | |
| Owen Adams Catherine | Director | M — Option exercise | 2.0K | $0.00 | — | SEC | |
| Goff Brian | Chief Executive Officer | M — Option exercise [10b5-1] | 13.5K | $0.00 | — | SEC | |
| Goff Brian | Chief Executive Officer | S — Open-market sale [10b5-1] | 12.5K | $34.71 | $433K | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for AGIOS PHARMACEUTICALS, INC. (AGIO). Updated in real time as new filings are submitted to the SEC.
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| CAPELLO JEFFREY D | 6 | — |
| Owen Adams Catherine | 6 | — |
| Gheuens Sarah | 5 | $151K |
| Foster-Cheek Kaye I | 4 | — |
| Backstrom Jay T. | 4 | — |
Form 144 must be filed before insiders sell restricted or control stock above SEC thresholds. A cluster of Form 144 notices often precedes a wave of insider distribution.
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in AGIO insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
Open the live AGIO dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.